Ahead of the 2023 reauthorization of the Biomedical Advanced Research and Development Authority (BARDA), the Pandemic and All Hazards Preparedness Act (PAHPA) 2023 policy memo outlines GHTC’s priorities for the reauthorization of BARDA.
Examines successes and pain points of the World Health Organization’s (WHO) Prequalification Program, which facilitates global access to safe, effective, and quality-assured products, and offers actionable recommendations to WHO to continue to strengthen the program to make it more fit for purpose for an evolving regulatory ecosystem
Calls on world leaders to prioritize action in four key areas to close the critical R&D, manufacturing, and delivery gaps necessary to end the acute COVID-19 crisis and build a more resilient, equitable pandemic R&D ecosystem for the future.
Outlines a policy proposal for a Supporting Innovative Global Health Technologies (SIGHT) Fund to create a new and additive source of flexible, catalytic funding at the US Agency for International Development (USAID) to conduct research, development, and deployment of global health products through a new appropriation to the USAID Global Health Bureau.
Find out about GHTC’s membership options and the benefits of becoming a member.
Learn MoreWe bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.
